The Role of Sexual Transmission of HIV Infection among Injection and Non-Injection Drug Users

Journal of Urban Health

Volumn 80, Issue 3, 2003, Pages

  Strathdee, Steffanie A ^a   Sherman, Susan G ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

HIV interventions for drug users; HIV AIDS; Injection drug use; Sexual risk behavior

Indexed keywords

ADOLESCENT; ADULT; CONFERENCE PAPER; FEMALE; FOLLOW UP; HETEROSEXUALITY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTITUTION; RISK FACTOR; SEROCONVERSION; SEXUAL BEHAVIOR; SEXUAL TRANSMISSION; UNITED STATES;

EID: 0742266707     PISSN: 10993460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Des Jarlais DC, Friedman SR, Hopkins W. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users. Ann Intern Med. 1985;103:755-759.
2. Chaisson RE, Moss AR, Onishi R, et al. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. Am J Public Health. 1987;77:169-172.
3. Schoenbaum EE, Hartel D, Selwyn PA, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989;321:874-879.
4. Van Ameijden EJC, Coutinho RA. Maximum impact of HIV prevention measures targeted at injecting drug users. AIDS. 1998;12:625-633.
5. Marx R, Aral SO, Rolfs RT, et al. Crack, sex, and STDs. Sex Transm Dis. 1991;18(2):92-101.
6. Battjes RJ, Pickens RW, Amsel Z, et al. Heterosexual transmission of human immunodeficiency virus among intravenous drug users. J Infect Dis. 1990;162(5):1007-1011.
7. Des Jarlais DC, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behavior for HIV among injecting drug users: a quasi-randomized trial. Lancet. 1999;353(9165):1657-1661.
8. Metzger DS, Koblin B, Turner C, et al. Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team. Am J Epidemiol. 2000;152(2):99-106.
9. Macalino GE, Celentano DD, Latkin C, et al. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injecting drug users. AIDS Educ Prev. 2002;14(5):367-378.
10. Doherty MC, Garfein RS, Monterroso E, et al. Correlates of HIV infection among young adult short-term injection drug users. AIDS. 2000;14(6):717-726.
11. Patrick DM, Strathdee SA, Archibald CP, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS. 1997;8:437-445.
12. Tortu S, Beardsley M, Deren S, et al. The risk of HIV infection in a national sample of women with injection drug-using partners. Am J Public Health. 1994;84(8):1243-1249.
13. Kral A, Bluthenthal R, Lorvick J, et al. Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet. 2001;(357):9266. 1397-1401.
14. Strathdee SA, Galai N, Safoiean M. Gender differences in risk factors for HIV seroconversion among injection drug users: a ten-year perspective. Arch Int Med. 2001;161:1281-1288.
15. Vlahov D, Anthony JC, Munoz A, et al. The ALIVE Study: a longitudinal study of HIV-1 infection in intravenous drug users: description of methods. J Drug Issues. 1991;21:759-776.
16. Strathdee SA, Safaeian M, Doherty M, et al. Correlates of HIV infection among young new initiates to injection drug use in Baltimore, Maryland: 1994-2000. XIV International Conference on AIDS, Barcelona Spain, July 2002, Abstract number: WePeD6366.
17. Page-Shafer KA, Hahn JA, Lum P, et al. Prevalence and correlates of HIV infection among young injection drug users in San Francisco. J Acquir Immune Defic Syndr. 2002;31:422-431.
18. Nelson KE, Vlahov D, Solomon L, et al. Temporal trends of incident human immunodeficiency virus infection in a cohort of injecting drug users in Baltimore, MD. Arch Intern Med. 1995;155:1305-1311.
19. Spittal PM, Craib KJ, Wood E, et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Can Med Assoc J. 2002;166(7):894-899.
20. Celentano DD, Vlahov D, Cohn S, Anthony JC, Solomon L, Nelson KE. Risk factors for shooting gallery use and cessation among intravenous drug users. Am J Public Health. 1991;81(10):1291-1295.
21. Strathdee SA, Patrick DM, Archibald CP, et al. Social determinants predict needle sharing behavior among injection drug users in Vancouver, Canada. Addiction. 1997; 92(10):1291-1295.
22. Bluthenthal RN, Kral AH, Gee L, et al. Trends in HIV seroprevalence and risk among gay and bisexual men who inject drugs in San Francisco, 1988 to 2000. J Acquir Immune Defic Syndr. 2001;28(3):264-269.
23. Shoptaw S, Reback CJ, Freese TE. Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles. J Addict Dis. 2002;21(1):91-105.
24. Neaigus A, Miller M, Friedman, et al. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus. J Inf Dis. 2001;184(3):359-363.
25. Gyarmathy VA, Neaigus A, Miller M, et al. Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr. 2002;30(4):448-456.
26. Poulin C, Alary M, Bernier F, et al. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae among at-risk women, young sex workers, and street youth attending community organizations in Quebec City, Canada. Sex Transm Dis. 2001;28(8):437-443.
27. Latkin CA, Mandell W, Knowlton AR, et al. Gender differences in injection-related behaviors among injection drug users in Baltimore, Maryland. AIDS Educ Prev. 1998;10:257-263.
28. Miller M, Neaigus A. Sex partner support, drug use and sex risk among HIV-negative non-injecting heroin users. AIDS Care. 2002;14(6):801-813.
29. Walden, Vivien Margaret, Mwangulube Kondwani, et al. Measuring the impact of a behavior change intervention for commercial sex workers and their potential clients in Malawi. Health Educ Res. 1999;14(4):545-554.
30. MAP (Monitoring the AIDS Pandemic) Symposium Report: The status and trends of the HIV/AIDS epidemic in the world. XIV International AIDS Conference; Barcelona; July 2-4, 2002.
31. Strathdee SA. Sexual HIV transmission in the context of injection drug use: implications for interventions. Int J Drug Policy. 2003;14:79-81.
32. Saidel TJ, Des Jarlais D, Peerapatanapokin W, et al. Potential impact of HIV among injection drug users on heterosexual transmission in Asian settings: the Asian epidemic model. Int J Drug Policy. In press.